Transforming Retinal Disease Treatment with AXPAXLI™
Ocular Therapeutix is a biopharmaceutical company focused on developing and commercializing innovative therapies for diseases of the eye, utilizing its proprietary ELUTYX hydrogel platform to deliver sustained-release drug delivery directly to ocular tissues.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountSep 2025
Feb 2024
Jul 2014
Jan 2013
Feb 2011
Jan 2011
Jun 2009
Jan 2008
Oct 2006
Create a free account to see which investors have funded this company.
Create Free Account
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
Health insurance company using technology to make health care simple, affordable, and accessible.
Global clinical research organization specializing in early-stage clinical trials and bioanalytic...
